Diethylamine → HCID 58770838、化合物
反応式
C(O[C:6]([N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[C:23]3[C:18](=[CH:19][C:20]([O:24][CH2:25][CH2:26][CH2:27][N:28]4[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]4)=[CH:21][CH:22]=3)[N:17]=[CH:16][N:15]=2)[CH2:10][CH2:9]1)=[O:7])(C)(C)C.CCN(CC)CC.C(Cl)(OCC1C2C(=CC=CC=2)C2C1=CC=CC=2)=O.Cl.[N+](C1C=CC(OC(=O)[NH:71][C:72]2[CH:77]=[CH:76][C:75]([N:78]3[CH2:83][CH2:82][O:81][CH2:80][CH2:79]3)=[CH:74][CH:73]=2)=CC=1)([O-])=O.C(NCC)C>C(Cl)Cl>[N:78]1([C:75]2[CH:74]=[CH:73][C:72]([NH:71][C:6]([N:8]3[CH2:13][CH2:12][CH:11]([C:14]4[C:23]5[C:18](=[CH:19][C:20]([O:24][CH2:25][CH2:26][CH2:27][N:28]6[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]6)=[CH:21][CH:22]=5)[N:17]=[CH:16][N:15]=4)[CH2:10][CH2:9]3)=[O:7])=[CH:77][CH:76]=2)[CH2:79][CH2:80][O:81][CH2:82][CH2:83]1参加物
実験手順
4-[7-(3-piperazin-1-yl-propoxy)-quinazolin-4-yl]-piperidine-1-carboxylic acid tert-butyl ester (0.05 mmol), prepared as described in Example 118, was dissolved in anhydrous DCM (1 mL) and treated with Et3N (0.05 mmol) followed by FMOC-Cl (0.1 mmol) and the mixture was stirred at rt overnight and then washed with water thrice, then dried over anhydrous MgSO4, filtered and concentrated in vacuo. To this was added 3M HCl/MeOH (1 mL) and the mixture was stirred at rt for 2 h and then concentrated in vacuo and the residue was dissolved in a 1:1 mixture of DCM:MeOH, neutralized with excess Et3N and treated with (4-morpholin-4-yl-phenyl)-carbamic acid 4-nitrophenyl ester hydrochloride (0.06 mmol), as prepared by the method outlined in Example 66a. The mixture was stirred at rt overnight and then concentrated in vacuo and partitioned between water and DCM. DCM layer was drawn off, washed with water thrice, then dried over anhydrous MgSO4, filtered and concentrated in vacuo. The residue was purified by Preparative TLC (silica gel; DCM:MeOH:NH4OH; 90:9:1) to obtain the pure product. This was dissolved in anhydrous DCM (1 mL) and diethylamine (0.25 mL) was added and the mixture was stirred at rt overnight. It was then concentrated in vacuo and purified by Preparative TLC (silica gel; DCM:MeOH:NH4OH; 90:9:1) to obtain 2.8 mg (10%) of the title compound. 1H-NMR (300 MHz, CDCl3): 9.13 (s, 1H), 8.05 (d, 1H), 7.35-7.23 (m, 4H), 6.88 (d, 2H), 6.35 (s, 1H), 4.32-4.14 (m, 4H), 3.90-3.80 (m, 4H), 3.75-3.60 (m, 1H), 3.20-2.91 (m, 10H), 2.75-2.55 (m, 6H), 2.18-1.85 (m, 7H). LC/MS (ESI): 560.0 (MH)+.
後処理
- washwashed with water thrice
- dry with materialdried over anhydrous MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- additionTo this was added 3M HCl/MeOH (1 mL)
- stirringthe mixture was stirred at rt for 2 h
- concentrationconcentrated in vacuo
- dissolutionthe residue was dissolved in a 1:1 mixture of DCM
- customas prepared by the method
- stirringThe mixture was stirred at rt overnight
- concentrationconcentrated in vacuo
- custompartitioned between water and DCM
- washwashed with water thrice
- dry with materialdried over anhydrous MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by Preparative TLC (silica gel; DCM:MeOH:NH4OH; 90:9:1)
- customto obtain the pure product
- stirringthe mixture was stirred at rt overnight
- concentrationIt was then concentrated in vacuo
- custompurified by Preparative TLC (silica gel; DCM:MeOH:NH4OH; 90:9:1)
出典と根拠
- ORDレコード
- ord-fc345979f314433ebdb878e786885277
- 出典データセット
- uspto-grants-2011_12
- 特許番号
- US08071768B2
反応ノート
読み込み中…